April 22, 2024

Swiss Biotech Day 2026

Swiss Biotech Day 2026

Swiss Biotech Day 2026

The power of international collaboration

Since 2021, the Swiss Biotech Day has seen remarkable growth every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations. It was by far the biggest and most international edition of the Swiss Biotech Day ever.

Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.


BioRN members receive a discount on ticket prices (reduced rate of CHF 500) – only 20 tickets available – first come, first serve.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.


Aufruf: Kostenerstattung für Teilnahme von KMU an Swiss Biotech Day

Webseite mit allen Infos: https://www.eureka.dlr.de/de/198.php 

Das BMFTR bietet deutschen KMU eine Unterstützung für die Teilnahme am Global Innovation und am Swiss Biotech Day in Form einer Kostenerstattung.
Für jeweils ein/e Vertreter/in von maximal 30 deutschen KMU können die folgenden Kosten erstattet werden:

  • Kosten für An- und Abreise von Deutschland nach Basel und zurück
  • Kosten für Unterkunft: maximal 4 Nächte im Zeitraum von 3. bis 7. Mai 2026, gem. aktuellen Sätzen des Bundesreisekostengesetzes (BRKG) bis zu 195 EUR pro Nacht (darüber hinausgehende Kosten müssen selbst getragen werden)
  • Optional: Teilnahmegebühren (registration fee) für Swiss Biotech Day
  • Optional: Verpflegungspauschalen (Tagessätze) nach dem BRKG

Die Kostenerstattung erfolgt grundsätzlich nach den Regelungen und Vorgaben des BRKG. Die Kosten werden rückwirkend nach Abschluss der Reise bei Vorlage entsprechender Belege erstattet.

Voraussetzungen für die Teilnahme

Es gelten die folgenden Voraussetzungen:

  • Unternehmen, die der KMU-Definition der EU entsprechen
  • Unternehmen, die operativ im Bereich der Biotechnologie tätig sind (z.B. Forschung und Entwicklung; Produkte, Verfahren und Dienstleistungen, einschließlich digitaler und datenbasierter Innovationen)

Beide Voraussetzungen müssen erfüllt sein.

Von der Teilnahme ausgeschlossen sind:

  • Unternehmen, die nicht der KMU-Definition der EU entsprechen (z.B. Großunternehmen)
  • Unternehmen mit dem ausschließlichen oder vorwiegenden operativen Geschäft im Bereich der Unternehmensberatung
  • Hochschulen und Forschungseinrichtungen

Frist für Interessensbekundungen und Auswahl

Das BMFTR bittet geeignete KMU, ihr Interesse bis zum 24. April 2026 per E-Mail gegenüber dem Eureka-Büro Deutschland zu bekunden:
eureka@dlr.de

register now

Our latest News

discover more
The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp